H.R. 1732 · 115th Congress
Synthetic Drug Control Act of 2017
- Stage
- In committee
- Sponsor
- Charles Dent
- Introduced
- 2017-03-27
- Latest action
- 2017-04-12 · Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Summary
Synthetic Drug Control Act of 2017
This bill directs the Drug Enforcement Administration to update schedule I of the Controlled Substances Act to include certain synthetic substances. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
The bill exempts from treatment as a controlled substance any such synthetic substance that is manufactured, distributed, and used exclusively for research.